| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $389.1M | +33.9% |
| R&D Expense | $58.0M | +8.3% |
| SG&A Expense | $146.7M | +29.1% |
| Operating Income | $161.3M | +145.5% |
| Pre-tax Income | $189.5M | +98.7% |
| Income Tax | -$15.4M | -347.9% |
| Net Income | $204.8M | +129.7% |
| EPS (Basic) | $7.08 | +126.9% |
| EPS (Diluted) | $6.84 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $496.3M | +43.9% |
| Accounts Receivable | $127.4M | +21.7% |
| Inventory | $40.5M | +52.7% |
| Current Assets | $1.02B | +38.1% |
| Total Assets | $1.33B | +26.3% |
| Current Liabilities | $102.9M | +0.9% |
| Total Liabilities | $114.2M | +4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $200.9M | +62.7% |
| Capital Expenditures | $12.0M | +182.0% |
| Investing Cash Flow | -$58.4M | +64.3% |
| Financing Cash Flow | $8.7M | -67.8% |
| Free Cash Flow | $188.9M | +58.5% |
| +128.0% |
| Stockholders' Equity |
| $1.22B |
| +28.9% |